About McMaster Children's Hospital at Hamilton Health Sciences
McMaster Children's Hospital, in Hamilton, Ontario, is one of Canada's largest pediatric academic tertiary care teaching hospitals affiliated with McMaster University. It is operated by Hamilton Health Sciences and is within the McMaster University Medical Centre. MCH became a children's hospital in 1988.
There are 165 beds in McMaster Children's Hospital at Hamilton Health Sciences.
Clinical Trials at McMaster Children's Hospital at Hamilton Health Sciences
During the past decade, McMaster Children's Hospital at Hamilton Health Sciences conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 68 clinical trials were completed, i.e. on
average, 62.4% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 29 clinical trials were completed. i.e. 65.9%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "McMaster Children's Hospital at Hamilton Health Sciences" #1 sponsor was "Children's Oncology Group" with 113 trials, followed by "National Cancer Institute (NCI)" with 26 trials
sponsored, "McMaster University" with 24 trials sponsored, "McMaster Children's Hospital" with 16 trials sponsored and "The Hospital for Sick Children"
with 16 trials sponsored. Other sponsors include 64 different institutions and
companies that sponsored additional 45 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "McMaster Children's Hospital at Hamilton Health Sciences"
#1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "Children's Hospital of Eastern Ontario" with 13 trials as a collaborator, "McMaster University" with 13 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 12 trials as a collaborator and "London Health Sciences Centre" with 12 trials as a collaborator. Other collaborators include 169 different institutions and companies that were
collaborators in the rest 112 trials.
Clinical Trials Conditions at McMaster Children's Hospital at Hamilton Health Sciences
According to Clinical.Site data, the most researched conditions in "McMaster Children's Hospital at Hamilton Health Sciences" are
"Leukemia" (21 trials), "Sarcoma" (15 trials), "Lymphoma" (13 trials), "Neuroblastoma" (12 trials) and "Acute Lymphoblastic Leukemia" (7 trials). Many other conditions were trialed in "McMaster Children's Hospital at Hamilton Health Sciences" in a lesser frequency.
Clinical Trials Intervention Types at McMaster Children's Hospital at Hamilton Health Sciences
Most popular intervention types in "McMaster Children's Hospital at Hamilton Health Sciences" are "Drug" (154 trials), "Other" (91 trials), "Biological" (74 trials), "Procedure" (56 trials) and "Radiation" (50 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "Cyclophosphamide" (32 trials), "Vincristine Sulfate" (28 trials), "cyclophosphamide" (28 trials) and "etoposide" (28 trials). Other intervention names were less common.
Clinical Trials Genders at McMaster Children's Hospital at Hamilton Health Sciences
The vast majority of trials in "McMaster Children's Hospital at Hamilton Health Sciences" are
252 trials for "All" genders, 9 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at McMaster Children's Hospital at Hamilton Health Sciences
Currently, there are 94 active trials in "McMaster Children's Hospital at Hamilton Health Sciences".
3 are not yet recruiting,
44 are recruiting,
46 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 151 completed trials in McMaster Children's Hospital at Hamilton Health Sciences,
1 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in McMaster Children's Hospital at Hamilton Health Sciences, 21 "Phase 1"
clinical trials were conducted, 66 "Phase 2" clinical
trials and 91 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 46 trials that are defined as “Not Applicable".